Eisai and Wren Therapeutics to collaborate for drug discovery for synucleinopathies
This collaboration aims to develop a disease-modifying treatment for synucleinopathies based on network kinetics of α-synuclein…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.